Evaluation and management of infectious esophagitis in immunocompromised patients and immunocompetent individuals

Cover Page

Cite item

Full Text

Abstract

Among the many causes of the inflammatory process in the esophagus, infectious diseases are becoming increasingly important due to their steady growth. Previously esophageal infections have traditionally been associated with immunodeficiency syndromes, but now in clinical practice, these disorders are becoming increasingly recognized in immunocompetent individuals. Early diagnosis of infectious esophagitis is necessary to develop effective treatment tactics, and, as a result, reduce the risk of complications and adverse outcomes of the disease. This study reviewed the most clinical relevant pathogens of infectious esophagitis, both among patients with immunodeficiency and among healthy individuals. Specific diagnostic, risk factors, clinical presentation and therapeutic features were considered depending on the immune status of patients.

About the authors

A. S. Trukhmanov

Sechenov First Moscow State Medical University (Sechenov University)

Email: makushinanast@gmail.com
ORCID iD: 0000-0003-3362-2968

д.м.н., проф. каф. пропедевтики внутренних болезней, гастроэнтерологии, гепатологии Института клинической медицины им. Н.В. Склифосовского ФГАОУ ВО «Первый МГМУ им. И.М. Сеченова» (Сеченовский Университет)

Russian Federation, Moscow

A. A. Makushina

Sechenov First Moscow State Medical University (Sechenov University)

Author for correspondence.
Email: makushinanast@gmail.com
ORCID iD: 0000-0002-1390-2981

студентка международной школы «Медицина будущего» ФГАОУ ВО «Первый МГМУ им. И.М. Сеченова» (Сеченовский Университет)

Russian Federation, Moscow

O. A. Storonova

Sechenov First Moscow State Medical University (Sechenov University)

Email: makushinanast@gmail.com
ORCID iD: 0000-0002-0960-1166

к.м.н., врач отд-ния функциональной диагностики Клиники пропедевтики внутренних болезней, гастроэнтерологии и гепатологии им. В.Х. Василенко ФГАОУ ВО «Первый МГМУ им. И.М. Сеченова» (Сеченовский Университет)

Russian Federation, Moscow

N. Yu. Ivashkina

Sechenov First Moscow State Medical University (Sechenov University)

Email: makushinanast@gmail.com
ORCID iD: 0000-0002-0847-9234

д.м.н., доц. каф. пропедевтики внутренних болезней и гастроэнтерологии ФГБОУ ВО «МГМСУ им. А.И. Евдокимова»

Russian Federation, Moscow

References

  1. Hoversten P, Kamboj A, Katzka D. Infections of the esophagus: an update on risk factors, diagnosis, and management. Dis Esophagus. 2018;31(12). doi: 10.1093/dote/doy094
  2. Mulhall BP, Wong RK. Infectious esophagitis. Current treatment options in gastroenterology. 2003;6(1):55-70. doi: 10.1007/s119ы38-003-0034-5
  3. Wilcox CM. Esophagitis in the immunocompromised host. In: Castell DO, Richter JE, eds. The esophagus, 5th ed. Philadelphia: Lippincott-Raven, 2012:724-39. doi: 10.1002/9781444346220.ch39
  4. Ивашкин В.Т., Ющук Н.Д., Маев И.В. и др. Клинические рекомендации Российской гастроэнтерологической ассоциации по диагностике и лечению инфекционного эзофагита. Рос. журн. гастроэнтерологии, гепатологии, колопроктологии. 2015 [Ivashkin VT, Juschuk ND, Maev IV, et al. Klinicheskie rekomendacii Rossijskoj gastrojenterologicheskoj associacii po diagnostike i lecheniju infekcionnogo jezofagita. Ros. zhurn. gastrojenterologii, gepatologii, koloproktologii. 2015 (In Russ.)].
  5. Alsomali MI, Arnold MA, Frankel WL, et al. Challenges to «Classic» esophageal candidiasis. Am J Clin Pathol. 2017;147:33-42. doi: 10.1093/ajcp/aqw210
  6. Robertson KD, Mehta D. Esophageal Candidiasis. In: StatPearls. StatPearls Publishing; 2019. https://www.ncbi.nlm.nih.gov/books/ NBK537268/
  7. Wilcox CM, Karowe MW. Esophageal infections: etiology, diagnosis, and management. Gastroenterologist. 1994;2:188-206.
  8. Baehr PH, McDonald GB. Esophageal infections: risk factors, presentation, diagnosis, and treatment. Gastroenterology. 1994;106:509-32. doi: 10.1016/0016-5085(94)90613-0
  9. McGuinness FE. Tuberculosis of the Gastrointestinal Tract and Peritoneum. In: Clinical Imaging in Non-Pulmonary Tuberculosis. Springer, Berlin, Heidelberg. 2000.
  10. Gill RA, Gebhard RL, Dozeman RL, Sumner HW. Shingles esophagitis: endoscopic diagnosis in two patients. Gastrointestinal Endoscopy. 1984;30:26-7. doi: 10.1016/s0016-5107(84)72290-5
  11. Winkler B, Capo V, Reumann W, et al. Human papillomavirus infection of the esophagus. A clinicopathologic study with demonstration of papillomavirus antigen by the immunoperoxidase technique. Cancer. 1985;55:149-55. doi: 10.1002/1097-0142(19850101)55:1<149::aid-cncr2820550123>3.0.co;2-9
  12. Rosołowski M, Kierzkiewicz M. Etiology, diagnosis and treatment of infectious esophagitis. Prz Gastroenterol. 2013;8(6):333-7. doi: 10.5114/pg.2013.39914
  13. Forrest G. Gastrointestinal infections in immunocompromised hosts. Curr Opin Gastroenterology. 2004;20(1):16-21. doi: 10.1097/00001574-200401000-00005
  14. Ahuja NK, Clarke JО. Evaluation and Management of Infectious Esophagitis in Immunocompromised and Immunocompetent Individuals. Curr Treatment Options Gastroenterol. 2016;14. doi: 10.1007/s11938-016-0082-2
  15. Lopez-Dupla M, Mora Sanz P, Pintado Garcia V. Clinical, endoscopic, immunologic, and therapeutic aspects of oropharyngeal and esophageal candidiasis in HIV-infected patients: a survey of 114 cases. Am J Gastroenterol. 1992;87:1771-6.
  16. Itoh T, Takahashi T, Kusaka K, et al. Herpes simplex esophagitis from 1307 autopsy cases. J Gastroenterol Hepatol. 2003;18:12. doi: 10.1046/j.1440-1746.2003.03166.x
  17. Hoversten P, Wu T-T, Katzka D. Variations in the Clinical Course of Patients With Herpes Simplex Virus Esophagitis Based on Immunocompetence and Presence Underlying Esophageal Disease: 413. Am J Gastroenterol. 2018;113:243-5. doi: 10.14309/00000434-201810001-00413
  18. Шулешова А.Г., Минушкин О.Н., Данилов Д.В., Бондарева К.А. Изучение персистенции вирусной инфекции в слизистой оболочке пищевода и ее возможная роль в развитии эрозивного эзофагита; лечебные подходы. Кремлевская медицина. Клин. вестн. 2017;3:105-11 [Shuleshova AG, Minushkin ON, Danilov DV, Bondareva KA. Izuchenie persistencii virusnoĭ infekcii v slizistoĭ obolochke pishhevoda i ee vozmozhnaja rol’ v razvitii jerozivnogo jezofagita; lechebnye podhody. Kremlevskaja medicina. Klin. vestn. 2017;3:105-11 (In Russ.)].
  19. Jones C. Alphaherpesvirus latency: its role in disease and survival of the virus in nature. Advanc Virus Res. 1998;51:81-133. doi: 10.1016/s0065-3527(08)60784-8
  20. Wagner EK, Bloom DC. Experimental investigation of herpes simplex virus latency. Clin Microbiol Rev. 1997;10(3):419-43. doi: 10.1128/cmr.10.3.419
  21. Clinton J. Herpes Simplex Virus Type 1 and Bovine Herpesvirus 1 Latency. Clin Microbiol Rev. 2003;16(1):79-95. doi: 10.1128/CMR.16.1.79-95.2003
  22. Robbins and Cotran Pathologic Basis of Disease, Professional Edition 8th Vinay Kumar Abul Abbas Nelson Fausto Jon Aster. 2014.
  23. Mosimann F, Cuenoud PF, Steinhauslin F, Wauters JP: Herpes simplex esophagitis after renal transplantation. Transplant Int. 1994;7(2):79-82. doi: 10.1111/j.1432-2277.1994.tb01224.x
  24. McBane RD, Gross JB Jr. Herpes esophagitis: clinical syndrome, endoscopic appearance, and diagnosis in 23 patients. Gastrointestinal Endoscopy. 1991;37:600-3. doi: 10.1016/s0016-5107(91)70862-6
  25. Burrig KF, Borchard F, Feiden W, Pftizer P. Herpes oesophagitis. II. Electron microscopical findings. Virchows Arch A Pathol Anat Histopathol. 1984;404:177-85. doi: 10.1007/bf00704062
  26. Feiden W, Borchard F, Burrig KF, Pfitzer P. Herpes oesophagitis. I. Light microscopical and immunohistochemical investigations. Virchows Arch A Pathol Anat Histopathol. 1984; 404:167-76. doi: 10.1007/bf00704061
  27. Jazeron JF, Barbe C, Frobert E, et al. Virological diag- nosis of herpes simplex virus 1 esophagitis by quantitative real-time PCR assay. J Clin Microbiol. 2012;50:948-52. doi: 10.1128/jcm.05748-11
  28. Canalejo E, García DF, Cabello N, García MJ. Herpes esophagitis in healthy adults and adolescents: report of 3 cases and review of the literature. Medicine. 2010;89(4):204-10. doi: 10.1097/md.0b013e3181e949ed
  29. Marinho AV, Bonfim VM, de Alencar LR, et al. Herpetic esophagitis in immunocompetent medical student. Case Rep Infect Dis. 2014;2014:930459. doi: 10.1155/2014/930459
  30. Wishingrad M. Sexually transmitted esophagitis: primary herpes simplex virus type 2 infection in a healthy man. Gastrointest Endosc. 1999;50:845-6. doi: 10.1016/s0016-5107(99)70172-0
  31. DiPalma JA, Brady CE. Herpes simplex esophagitis in a nonimmunosuppressed host with gastroesophageal reflux. Gastrointest Endosc. 1984;30:24-5. doi: 10.1016/s0016-5107(84)72289-9
  32. Galbraith JCT, Shafran SD. Herpes simplex esophagitis in the immunocompetent patient: report of four cases and review. Clin Infect Dis. 1992;14:894-901. doi: 10.1093/clinids/14.4.894
  33. Buss DH, Scharyj M. Herpes virus infection of the esophagus and other visceral organs in adults. Incidence and clinical significance. Am J Med. 1979;66:457-62. doi: 10.1016/0002-9343(79)91068-4
  34. Genereau T, Rozenberg F, Bouchaud O, et al. Herpes esophagitis: a comprehensive review. Clin Microbiol Infect. 1997;3:397-407. doi: 10.1111/j.1469-0691.1997.tb00275.x
  35. Nash G, Ross JS. Herpetic esophagitis: a common cause of esophageal ulceration. Hum Pathol. 1974;5:339-45. doi: 10.1016/s0046-8177(74)80116-4
  36. Pazin GJ. Herpes simplex esophagitis after trigeminal nerve surgery. Gastroenterology. 1978;74:741-3. doi: 10.1016/0016-5085(78)90254-8
  37. Ashcraft KA, Hunzeker J, Bonneau RH. Psychological stress impairs the local CD8+ T cell response to mucosal HSV-1 infection and allows for increased pathogenicity via a glucocorticoid receptor-mediated mechanism. Psychoneuroendocrinology. 2008;33(7):951-63. doi: 10.1016/j.psyneuen.2008.04.010
  38. Lindberg G, Eldik R, Saboorian M. A case of herpes esophagitis after fluticasone propionate for eosinophilic esophagitis. Nature clinical practice. Gastroenterol Hepatol. 2008;5:527-30. doi: 10.1038/ncpgasthep1225
  39. Zimmermann D. Acute Herpes Simplex Viral Esophagitis Occurring in 5 Immunocompetent Individuals With Eosinophilic Esophagitis. ACG Case Reports J. 2016;3:165-8. doi: 10.14309/crj.2016.38
  40. Franulovic ŽO, Lesar T, Busic N, Tešović G. Herpes simplex primo infection in an immunocompetent host with eosinophilic esophagitis. Pediatr Int. 2013;55(3):e38-41. doi: 10.1111/ped.12027
  41. Squires KA, Cameron DJ, Oliver M, de Fonseca Junqueira JC. Herpes simplex and eosinophilic oesophagitis: The chicken or the egg? J Pediatr Gastroenterol Nutr. 2009;49(2):246-50. doi: 10.1097/mpg.0b013e31817b5b73
  42. Monsanto P, Almeida N, Cipriano MA, et al. Concomitant herpetic and eosinophilic esophagitis: A causality dilemma. Acta Gastroenterol Belg. 2012;75(3):361-3.
  43. Sherrill JD, Kc K, Wu D, et al. Desmoglein-1 regulates esophageal epithelial barrier function and immune responses in eosinophilic esophagitis. Mucosal Immunol. 2014;7(3):718-29. doi: 10.1038/mi.2013.90
  44. Kato S, Yamamoto R, Yoshimitsu S, et al. Herpes simplex esophagitis in the immunocompetent host. Dis Esophagus. 2005;18(5):340-4. doi: 10.1111/j.1442-2050.2005.00510.x
  45. Ramanathan J, Rammouni M, Baran Jr J, et al. Herpes simplex virus esophagitis in the immunocompetent host: an overview. Am J Gastroenterol. 2000;95:2171-6. doi: 10.1111/j.1572-0241.2000.02299.x
  46. Шестакова И.В., Малышев Н.А., Лебедев В.В. и др. Клинические рекомендации. Цитомегаловирусная болезнь у взрослых. 2016 [Shestakova IV, Malyshev NA, Lebedev VV, et al. Klinicheskie rekomendacii. Citomegalovirusnaja bolezn’ u vzroslyh. 2016 (In Russ.)]. https://medi.ru/klinicheskie-rekomendatsii/tsitomegalovirusnaya-bolezn-u-vzroslykh_14305/
  47. Wang HW, Kuo CJ, Lin WR, et al. The clinical characteristics and manifestations of cytomegalovirus esophagitis. Dis Esophagus. 2016;29:392-9. doi: 10.1111/dote.12340
  48. Marques S, Carmo J, Pinto D, et al. Cytomegalovirus disease of the upper gastrointestinal tract: a 10-year retrospective study. GE Port J Gastroenterol. 2017;24:262-8. doi: 10.1159/000479232
  49. Bonetti LR, Losi L, Greagorio C, et al. Cytomegalovirus infection of the upper gastrointestinal tract: a clinical and pathological study of 30 cases. Scand J Gastroenterol. 2011;46:1228-35. doi: 10.3109/00365521.2011.594083
  50. Péter A, Telkes G, Varga M, et al. Endoscopic diagnosis of cytomegalovirus infection of upper gastrointestinal tract in solid organ transplant recipients: Hungarian single-center experience. Clin Transplant. 2004;18:580-4. doi: 10.1111/j.1399-0012.2004.00230.x
  51. Wilcox CM, Straub RF, Schwartz DA. Prospective endoscopic characterization of cytomegalovirus esophagitis in AIDS. Gastrointest Endosc. 1994;40:481-4. doi: 10.1016/s0016-5107(94)70215-2
  52. Featherstone RJ, Camero LG, Khatib R, et al. Massive esophageal bleeding in achalasia complicated by cytomegalovirus esophagitis. Ann Thorac Surg. 2005;59:1021-2. doi: 10.1016/0003-4975(94)00744-r
  53. Kanda K, Kume K, Yoshikawa I, et al. Cytomegalovirus esophagitis with massive upper GI hemorrhage. Gastrointest Endosc. 2004;59:741-3. doi: 10.1016/s0016-5107(04)00184-1
  54. Mayeux GP, Smith JW. Massive esophageal bleeding from cytomegalovirus esophagitis. Am J Gastroenterol. 1990;85:626. doi: 10.1016/0003-4975(94)00744-r
  55. Theise ND, Rotterdam H, Dieterich D. Cytomegalovirus esophagitis in AIDS: diagnosis by endoscopic biopsy. Am J Gastroenterol. 1991;86:1123-6.
  56. Maiorana A, Baccarini P, Foroni M, et al. Human cytomegalovirus infection of the gastrointestinal tract in apparently immunocompetent patients. Hum Pathol. 2003;34:1331-6. doi: 10.1016/j.humpath.2003.08.005
  57. Weile J, Streeck B, Muck J, et al. Severe cytomegalovirusassociated esophagitis in an immunocompetent patient after short-term steroid therapy. J Clin Microbiol. 2009;47:3031-3. doi: 10.1128/jcm.00143-09
  58. Rafailidis PI, Mourtzoukou EG, Varbobitis IC, et al. Severe cytomegalovirus infection in apparently immunocompetent patients: a systematic review. Virol J. 2008;5:47. doi: 10.1186/1743-422x-5-47
  59. Wreghitt TG, Teare EL, Sule O, et al. Cytomegalovirus infection in immunocompetent patients. Clin Infect Dis. 2003;37:1603-6. doi: 10.1086/379711
  60. Limaye AP, Kirby KA, Rubenfeld GD, et al. Cytomegalovirus reactivation in critically ill immunocompetent patients. JAMA. 2008;300:413-22. doi: 10.1001/jama.2008.697
  61. Lim DS, Lee TH, Jin SY, et al. Cytomegalovirus esophagitis in an immunocompetent patient: case report. Turk J Gastroenterol. 2014;25:571-4. doi: 10.5152/tjg.2014.4073
  62. Sylwester AW, et al. Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects. J Exp Med. 2005;202:673-85. doi: 10.1084/jem.20050882
  63. Greenberg PD, Riddell SR. Deficient cellular immunity-finding and fixing the defects. Science. 1999;285:546-51. doi: 10.1126/science.285.5427.546
  64. Reddehase MJ. Antigens and immunoevasins: opponents in cytomegalovirus immune surveillance. Nat Rev Immunol. 2002;2:831-44. doi: 10.1038/nri932
  65. Einsele HE, Rufer RN, Sinzger C, et al. Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy. Blood. 2002;99:3916-22. doi: 10.1182/blood.v99.11.3916
  66. Daniell HW. Acid suppressing therapy as a risk factor for Candida esophagitis. Dis Esophagus. 2016;29:479-83. doi: 10.1111/dote.12354
  67. Yakoob J, Jafri W, Abid S, et al. Candida esophagitis: risk factors in non-HIV population in Pakistan. World J Gastroenterol. 2003;9:2328-31. doi: 10.1111/j.1572-0241.2003.07772.x
  68. Underwood JA, Williams JW, Keate RF. Clinical findings and risk factors for Candida esophagitis in outpatients. Dis Esophagus. 2003;16:66-9. doi: 10.1046/j.1442-2050.2003.00305.x
  69. Mimidis K, Papadopoulos V, Margaritis V, et al. Predisposing factors and clinical symptoms in HIV-negative patients with Candida oesophagitis: Are they always present? Int J Clin Pract. 2005;59:210-3. doi: 10.1111/j.1742-1241.2004.00249.x
  70. Asayama N, Nagata N, Shimbo T, et al. Relationship between clinical factors and severity ofesophageal candidiasis according to Kodsi’s classification. Dis Esophagus. 2014;27:214-9. doi: 10.1111/dote.12102
  71. Kodsi BE, Wickremesinghe C, Kozinn PJ, et al. Candida esophagitis:a prospective study of 27 cases. Gastroenterology. 1976;71:715-9. doi: 10.1016/s0016-5085(76)80347-2
  72. Pappas PG, Kauffman CA, Andes D, et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;48:503-35. doi: 10.1086/596757
  73. Von AU, Malfertheiner P. Eosinophilic esophagitis – treatment of eosinophilic esophagitis with drugs: corticosteroids. Dig Dis. 2014;32:126-9. doi: 10.1159/000357089
  74. Lee SP, Sung IK, Kim JH, et al. The clinical course of asymptomatic esophageal candidiasis incidentally diagnosed in general health inspection. Scand J Gastroenterol. 2015;50:1444-50. doi: 10.3109/00365521.2015.1057519
  75. Welzel TM, Kawan T, Bohle W, et al. An unusual cause of dysphagia: esophageal tuberculosis. J Gastrointestin Liver Dis. 2010;19: 321-4. doi: 10.1055/s-0029-1225742
  76. Кузьмина О.А., Таланова О.С., Холева А.О. и др. Туберкулез пищевода. Известия высших учебных заведений. Поволжский регион. Мед. науки. 2012;4(24):82-9 [Kuz’mina ОА, Talanova OS, Holeva AO, et al. Tuberkulez pishhevoda. Izvestija vysshih uchebnyh zavedenij. Povolzhskij region. Med. nauki. 2012;4(24):82-9 (In Russ.)].
  77. Jain SK, Jain S, Jain M, Yaduvanshi A. Esophageal tuberculosis: is it so rare? Report of 12 cases and review of the literature. Am J Gastroenterol. 2002;97:287-91. doi: 10.1111/j.1572-0241.2002.05456.x
  78. Jain SS, Somani PO, Mahey RC, et al. Esophageal tuberculosis presenting with hematemesis. World J Gastrointest Endosc. 2013;5(11):581-3. doi: 10.4253/wjge.v5.i11.581
  79. Чернеховская Н.Е. Эндоскопическая диагностика заболеваний пищевода, желудка. М.: МЕДпресс-информ, 2010 [Chernehovskaja NE. Endoscopic diagnosis of diseases of the esophagus, stomach. Moscow: MEDpress-inform, 2010 (In Russ.)].
  80. Mbiine, et al. Tuberculosis as a primary cause of oesophageal stricture: a case report. J Cardiothor Surg. 2018;13:58. doi: 10.1186/s13019-018-0743-4
  81. Muñoz N, Bosch FX, de Sanjosé, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003;348:518-27. doi: 10.1056/nejmoa021641
  82. Bohn OL, Navarro L, Saldivar J, Sanchez-Sosa S. Identification of human papillomavirus in esophageal squamous papillomas. World J Gastroenterol. 2008;14:7107. doi: 10.3748/wjg.14.7107
  83. Quarto G, Sivero L, Somma P, et al. A case of infectious esophagitis caused by human papilloma virus. Minerva Gastroenterol Dietol. 2008;54:317-21.
  84. Tabatabaei SA, Moghadam NA, Ahmadinejad M, et al. Giant esophageal squamous papilloma: a case report. J Dig Dis. 2009. doi: 10.1111/j.1751-2980.2009.00390.x
  85. Gençdal G, Degirmencioglu S, Akyıldız M. Diffuse esophageal squamous papillomatosis covering the entire esophagus. Clin Gastroenterol Hepatol. 2018;16:A28. doi: 10.1016/j.cgh.2017.09.020
  86. Lavergne D, de Villiers E-M. Papillomavirus in esophageal papillomas and carcinomas. Int J Cancer. 1999;80:681-4. doi: 10.1002/(sici)1097-0215(19990301)80:5<681::aid-ijc8>3.0.co;2-a
  87. Devuni D, Birk J, et al. Esophagitis Differential Diagnoses. Medscape article/174223. 2019. https://emedicine.medscape.com/article/174223-differential
  88. Krämer A, Kretzschmar M, Krickeberg K. Modern Infectious Disease Epidemiology: Concepts, Methods, Mathematical Models, and Public Health. 2010. doi: 10.1007/978-0-387-93835-6
  89. Brodin P, Jojic V, Gao T, et al. Variation in the Human Immune System Is Largely Driven by Non-Heritable Influences. Cell. 2015;160:37-47. doi: 10.1016/j.cell.2014.12.020
  90. Liston A, Carr E, Linterman M. Shaping Variation in the Human Immune System. Trends Immunol. 2016;37:637-46. doi: 10.1016/j.it.2016.08.002
  91. Hooper LV, Littman DR, Macpherson AJ. Interactions between the microbiota and the immune system. Science. 2012;336:1268-73. doi: 10.1126/science.1223490
  92. Gjevestad GO, et al. Effects of exercise on gene expression of inflammatory markers in human peripheral blood cells: a systematic review. Curr Cardiovasc Risk Rep. 2015;9:34. doi: 10.1007/s12170-015-0463-4

Copyright (c) 2020 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies